# Emergent BioSolutions Inc.: Form 8-K, filed Oct 5, 2018

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2018-10-05
- Accepted by EDGAR: Oct 4, 2018, 19:22 ET
- Period: 2018-10-04
- Accession: 0001104659-18-060601
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000110465918060601/a18-36350_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000110465918060601/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000110465918060601/a18-36350_18k.htm

Filed Oct 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001104659-18-060601. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
